What is the single most important message for policymakers?

In microbiological diagnostics, speed, accuracy and access determine survival. Yet the pathway from discovery to bedside to policy remains fragmented, with weak linkages between analytical validation and real-world performance. Limited contextualisation of diagnostics across diverse clinical settings, alongside persistent affordability barriers, continues to constrain translation of innovation into measurable impact on antimicrobial resistance (AMR). Multi-dimensional … Continued